Guangzhou Metro Design & Research Institute Co.Ltd(003013) : the net profit in 2021 increased by 24.45% year on year, and it is proposed to pay 4 yuan in 10
Guangzhou Metro Design & Research Institute Co.Ltd(003013) ( Guangzhou Metro Design & Research Institute Co.Ltd(003013) ) the annual report was disclosed on March 29. In 2021, the operating revenue was 2.381 billion yuan, a year-on-year increase of 27.28%; The net profit was 357 million yuan, a year-on-year increase of 24.45%; The basic earnings per share is 0.89 yuan. The company plans to pay a dividend of 4 yuan (including tax) for every 10 shares. During the reporting period, the company actively grasped the development of the core business of rail transit engineering consulting and maintained the continuous growth of business performance. Among them, the survey and design business in the field of rail transit is still the main part of the company’s performance; At the same time, the income from planning consulting business and general contracting business has increased steadily.
Hualan vaccine: the net profit in 2021 decreased by 32.86% year-on-year, and it is planned to pay 2 yuan for 10
Hualan vaccine (301207) disclosed its annual report on March 29. In 2021, it realized an operating revenue of 1.83 billion yuan, a year-on-year decrease of 24.59%; The net profit was 621 million yuan, a year-on-year decrease of 32.86%; The basic earnings per share is 1.72 yuan. The company plans to pay a dividend of 2 yuan (including tax) for every 10 shares. During the reporting period, the company completed the influenza vaccine production and batch issuance plan on time. However, due to the impact of covid-19 vaccine booster vaccination and covid-19 vaccine replacement for children under 12 years of age and other factors in the influenza sales season in the second half of the year, the influenza vaccine market sales work was greatly affected, resulting in a decline in the company’s revenue and net profit.
Sichuan Jinshi Technology Co.Ltd(002951) : the unsuccessful Hunan China tobacco project will have a significant adverse impact on the company’s performance
Sichuan Jinshi Technology Co.Ltd(002951) ( Sichuan Jinshi Technology Co.Ltd(002951) ) announcement on March 29, Recently, Jinshi printing, a wholly-owned subsidiary of the company, participated in the procurement and service project of Hunan China cigarette box and strip wrapping paper (April 2022 – June 2024) Bidding for items 7, 9, 13 and 14. According to the publicity, Jinshi printing is not in the list of bid winning candidates. The products related to the above bid sections are the products supplied by the company in 2021, accounting for 8.39%, 1.81%, 26.48% and 14.85% of the total revenue in the consolidated statements of the company in the first three quarters of 2021 respectively. The failure to win the bid will have a significant adverse impact on the future operating performance of the company.
Kunming Chuan Jin Nuo Chemical Co.Ltd(300505) : the net profit in 2021 increased by 356% year-on-year, and it is proposed to transfer 10 to 5 and distribute 2 yuan
Kunming Chuan Jin Nuo Chemical Co.Ltd(300505) ( Kunming Chuan Jin Nuo Chemical Co.Ltd(300505) ) announced on March 29 that the operating revenue in 2021 will reach 1.536 billion yuan, with a year-on-year increase of 46.3%; The net profit was 189 million yuan, a year-on-year increase of 355.83%; The basic earnings per share is 1.42 yuan. The company plans to increase 5 shares for every 10 shares and distribute a dividend of 2 yuan (including tax).
China Transinfo Technology Co.Ltd(002373) : expected net loss of 240 million yuan – 290 million yuan in the first quarter
China Transinfo Technology Co.Ltd(002373) ( China Transinfo Technology Co.Ltd(002373) ) announced on March 29 that the net profit attributable to the parent company in the first quarter of 2022 is expected to be RMB 240 million to RMB 290 million. During the reporting period, the impact of the decline in the fair value of Hangzhou Hopechart Iot Technology Co.Ltd(688288) ( Hangzhou Hopechart Iot Technology Co.Ltd(688288) ) held by the company on the net profit was about 190220 million yuan. The project belongs to non recurring profit and loss; At the same time, affected by the epidemic, the company’s product sales decreased year-on-year, and the delivery of transportation solution projects was partially delayed, resulting in the corresponding delay in revenue recognition.
Shares to be increased by 10
Bozhon Precision Industry Technology Co.Ltd(688097) ( Bozhon Precision Industry Technology Co.Ltd(688097) ) announced on March 29 that LV Shaolin, the actual controller, chairman and general manager of the company, plans to increase his holdings by 5-10 million yuan within 12 months from March 30.
Lanzhou Huanghe Enterprise Co.Ltd(000929) : the production and sales of Lanzhou fine wine, a subsidiary affected by the epidemic, basically stagnated
E company news, Lanzhou Huanghe Enterprise Co.Ltd(000929) ( Lanzhou Huanghe Enterprise Co.Ltd(000929) ) announced on March 29 that due to epidemic prevention and control, the area where the production plant of the company’s subsidiary Lanzhou Huanghe Enterprise Co.Ltd(000929) fine Brewing Beer Co., Ltd. (hereinafter referred to as “Lanzhou fine brewing”) is still not unsealed, and its production and marketing activities have basically stagnated since late March this year, which will have a certain impact on the company’s performance in the first quarter of 2022. Considering that the current round of epidemic has caused great impact on catering, entertainment, tourism and other related industries in Gansu and Qinghai provinces, and the dynamic sales of beer products in the company’s local market has slowed down significantly since March this year, Lanzhou Jianiang will face more difficulties than before in restoring its normal production and sales level in the future, which may have an impact on the company’s main business development and performance completion in 2022.
\u3000\u3000
